Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RAS Blockade at Bedtime Versus on Awakening for the Prevention of Aldosterone Breakthrough

NCT01805362 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT01805362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01805362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RAS Blockade at Bedtime Versus on Awakening for the Prevention of Aldosterone Breakthrough
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Not applicable
Overall status
Completed
Start date
February 27, 2013
Completion date
January 12, 2018
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease